Next Article in Journal
Risk Factors for Death or Cardiovascular Events after Acute Coronary Syndrome in Patients with Myeloproliferative Neoplasms
Next Article in Special Issue
Safe and Effective Administration of Caplacizumab in COVID-19-Associated Thrombotic Thrombocytopenic Purpura
Previous Article in Journal
Splenic Rupture Secondary to Amyloidosis: A Case Report and Review of the Literature
Previous Article in Special Issue
Role of Therapeutic Anticoagulation in COVID-19: The Current Situation
 
 
Conference Report

Article Versions Notes

Hematol. Rep. 2023, 15(2), 384-397; https://doi.org/10.3390/hematolrep15020039
Action Date Notes Link
article xml file uploaded 7 June 2023 04:20 CEST Original file -
article xml uploaded. 7 June 2023 04:20 CEST Update https://www.mdpi.com/2038-8330/15/2/39/xml
article pdf uploaded. 7 June 2023 04:20 CEST Version of Record https://www.mdpi.com/2038-8330/15/2/39/pdf
article html file updated 7 June 2023 04:22 CEST Original file -
article html file updated 7 June 2023 04:23 CEST Update -
article html file updated 7 June 2023 04:24 CEST Update -
article html file updated 20 June 2023 21:00 CEST Update https://www.mdpi.com/2038-8330/15/2/39/html
Back to TopTop